메뉴 건너뛰기




Volumn 18, Issue 5, 2012, Pages 412-419

The efficacy of FDG-PET for the management of esophageal cancer: Review article

Author keywords

Esophageal cancer; FDG PET; PET CT; Staging; SUV

Indexed keywords

ANTINEOPLASTIC AGENT; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

EID: 84869219596     PISSN: 13411098     EISSN: 21861005     Source Type: Journal    
DOI: 10.5761/atcs.ra.12.01954     Document Type: Review
Times cited : (37)

References (66)
  • 1
    • 34249052900 scopus 로고    scopus 로고
    • Surgical treatment for esophageal cancer. Current issues
    • Kato H, Fukuchi M, Miyazaki T, et al. Surgical treatment for esophageal cancer. Current issues. Dig Surg 2007; 24: 88-95.
    • (2007) Dig Surg , vol.24 , pp. 88-95
    • Kato, H.1    Fukuchi, M.2    Miyazaki, T.3
  • 2
    • 3042760774 scopus 로고    scopus 로고
    • Neoplasms of the esophagus and stomach
    • Dehdashti F, Siegel BA. Neoplasms of the esophagus and stomach. Semin Nucl Med 2004; 34: 198-208.
    • (2004) Semin Nucl Med , vol.34 , pp. 198-208
    • Dehdashti, F.1    Siegel, B.A.2
  • 3
    • 0028211534 scopus 로고
    • Neoadjuvant therapy for squamous cell esophageal carcinoma
    • Fink U, Stein HJ, Bochtler H, et al. Neoadjuvant therapy for squamous cell esophageal carcinoma. Ann Oncol 1994; 5: 17-26.
    • (1994) Ann Oncol , vol.5 , pp. 17-26
    • Fink, U.1    Stein, H.J.2    Bochtler, H.3
  • 4
    • 0031667935 scopus 로고    scopus 로고
    • Neoadjuvant chemotherapy and hyperfractionated radiotherapy with concurrent low-dose chemotherapy for squamous cell esophageal carcinoma
    • Raoul JL, Le Prisé E, Meunier B, et al. Neoadjuvant chemotherapy and hyperfractionated radiotherapy with concurrent low-dose chemotherapy for squamous cell esophageal carcinoma. Int J Radiat Oncol Biol Phys 1998; 42: 29-34.
    • (1998) Int J Radiat Oncol Biol Phys , vol.42 , pp. 29-34
    • Raoul, J.L.1    Le Prisé, E.2    Meunier, B.3
  • 5
    • 0030819426 scopus 로고    scopus 로고
    • Improvement in staging of esophageal cancer with the addition of positron emission tomography
    • discussion 776-7
    • Block MI, Patterson GA, Sundaresan RS, et al. Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann Thorac Surg 1997; 64: 770-6; discussion 776-7.
    • (1997) Ann Thorac Surg , vol.64 , pp. 770-776
    • Block, M.I.1    Patterson, G.A.2    Sundaresan, R.S.3
  • 6
    • 0030769847 scopus 로고    scopus 로고
    • Role of positron emission tomography in staging esophageal cancer
    • Luketich JD, Schauer PR, Meltzer CC, et al. Role of positron emission tomography in staging esophageal cancer. Ann Thorac Surg 1997; 64: 765-9.
    • (1997) Ann Thorac Surg , vol.64 , pp. 765-769
    • Luketich, J.D.1    Schauer, P.R.2    Meltzer, C.C.3
  • 7
    • 0031016485 scopus 로고    scopus 로고
    • Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography
    • Flanagan FL, Dehdashti F, Siegel BA, et al. Staging of esophageal cancer with 18F-fluorodeoxyglucose positron emission tomography. AJR Am J Roentgenol 1997; 168: 417-24.
    • (1997) AJR Am J Roentgenol , vol.168 , pp. 417-424
    • Flanagan, F.L.1    Dehdashti, F.2    Siegel, B.A.3
  • 8
    • 0031715719 scopus 로고    scopus 로고
    • Computed tomography and positron emission tomography in the pre-operative staging of oesophageal carcinoma
    • Rankin SC, Taylor H, Cook GJ, et al. Computed tomography and positron emission tomography in the pre-operative staging of oesophageal carcinoma. Clin Radiol 1998; 53: 659-65.
    • (1998) Clin Radiol , vol.53 , pp. 659-665
    • Rankin, S.C.1    Taylor, H.2    Cook, G.J.3
  • 9
    • 0001049922 scopus 로고    scopus 로고
    • FDG-PET in Esophageal Cancer. Incremental Value over Computed Tomography
    • Yeung HW, Macapinlac HA, Mazumdar M, et al. FDG-PET in Esophageal Cancer. Incremental Value over Computed Tomography. Clin Positron Imaging 1999; 2: 255-60.
    • (1999) Clin Positron Imaging , vol.2 , pp. 255-260
    • Yeung, H.W.1    Macapinlac, H.A.2    Mazumdar, M.3
  • 10
    • 0037083439 scopus 로고    scopus 로고
    • Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma
    • Kato H, Kuwano H, Nakajima M, et al. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Cancer 2002; 94: 921-8.
    • (2002) Cancer , vol.94 , pp. 921-928
    • Kato, H.1    Kuwano, H.2    Nakajima, M.3
  • 11
    • 0037950340 scopus 로고    scopus 로고
    • Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study
    • Yoon YC, Lee KS, Shim YM, et al. Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG PET for presurgical detection prospective study. Radiology 2003; 227: 764-70.
    • (2003) Radiology , vol.227 , pp. 764-770
    • Yoon, Y.C.1    Lee, K.S.2    Shim, Y.M.3
  • 12
    • 4644236287 scopus 로고    scopus 로고
    • Systematic review of the staging performance of 18Ffluorodeoxyglucose positron emission tomography in esophageal cancer
    • van Westreenen HL, Westerterp M, Bossuyt PM, et al. Systematic review of the staging performance of 18Ffluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol 2004; 22: 3805-12.
    • (2004) J Clin Oncol , vol.22 , pp. 3805-3812
    • van Westreenen, H.L.1    Westerterp, M.2    Bossuyt, P.M.3
  • 13
    • 4043084865 scopus 로고    scopus 로고
    • Value of positron emission tomography in the diagnosis of recurrent oesophageal carcinoma
    • Kato H, Miyazaki T, Nakajima M, et al. Value of positron emission tomography in the diagnosis of recurrent oesophageal carcinoma. Br J Surg 2004; 91: 1004-9.
    • (2004) Br J Surg , vol.91 , pp. 1004-1009
    • Kato, H.1    Miyazaki, T.2    Nakajima, M.3
  • 14
    • 68549101761 scopus 로고    scopus 로고
    • The clinical application of (18)F-fluorodeoxyglucose positron emission tomography to predict survival in patients with operable esophageal cancer
    • Kato H, Nakajima M, Sohda M, et al. The clinical application of (18)F-fluorodeoxyglucose positron emission tomography to predict survival in patients with operable esophageal cancer. Cancer 2009; 115: 3196-203.
    • (2009) Cancer , vol.115 , pp. 3196-3203
    • Kato, H.1    Nakajima, M.2    Sohda, M.3
  • 15
    • 74649087061 scopus 로고    scopus 로고
    • Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma
    • Hyun SH, Choi JY, Shim YM, et al. Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma. Ann Surg Oncol 2010; 17: 115-22.
    • (2010) Ann Surg Oncol , vol.17 , pp. 115-122
    • Hyun, S.H.1    Choi, J.Y.2    Shim, Y.M.3
  • 16
    • 0035112099 scopus 로고    scopus 로고
    • Neoadjuvant therapy of esophageal squamous cell carcinoma: Response evaluation by positron emission tomography
    • Brücher BL, Weber W, Bauer M, et al. Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography. Ann Surg 2001; 233: 300-9.
    • (2001) Ann Surg , vol.233 , pp. 300-309
    • Brücher, B.L.1    Weber, W.2    Bauer, M.3
  • 17
    • 0036754534 scopus 로고    scopus 로고
    • Usefulness of positron emission tomography for assessing the response of neoadjuvant chemoradiotherapy in patients with esophageal cancer
    • Kato H, Kuwano H, Nakajima M, et al. Usefulness of positron emission tomography for assessing the response of neoadjuvant chemoradiotherapy in patients with esophageal cancer. Am J Surg 2002; 184: 279-83.
    • (2002) Am J Surg , vol.184 , pp. 279-283
    • Kato, H.1    Kuwano, H.2    Nakajima, M.3
  • 18
    • 78751627736 scopus 로고    scopus 로고
    • Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with potentially curable esophageal cancer
    • van Heijl M, Omloo JM, van Berge Henegouwen MI, et al. Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with potentially curable esophageal cancer. Ann Surg 2011; 253: 56-63.
    • (2011) Ann Surg , vol.253 , pp. 56-63
    • van Heijl, M.1    Omloo, J.M.2    van Berge Henegouwen, M.I.3
  • 19
    • 1842503945 scopus 로고    scopus 로고
    • 18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression
    • Yen TC, See LC, Lai CH, et al. 18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression. J Nucl Med 2004; 45: 22-9.
    • (2004) J Nucl Med , vol.45 , pp. 22-29
    • Yen, T.C.1    See, L.C.2    Lai, C.H.3
  • 20
    • 0031958510 scopus 로고    scopus 로고
    • FDG uptake, tumour characteristics and response to therapy: A review
    • Smith TA. FDG uptake, tumour characteristics and response to therapy: a review. Nucl Med Commun 1998; 19: 97-105.
    • (1998) Nucl Med Commun , vol.19 , pp. 97-105
    • Smith, T.A.1
  • 21
    • 0042029374 scopus 로고    scopus 로고
    • Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma
    • Kato H, Takita J, Miyazaki T, et al. Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma. Anticancer Res 2003; 23: 3263-72.
    • (2003) Anticancer Res , vol.23 , pp. 3263-3272
    • Kato, H.1    Takita, J.2    Miyazaki, T.3
  • 22
    • 0029073742 scopus 로고
    • Application of wholebody positron emission tomography in the imaging of esophageal cancer: Report of a case
    • Yasuda S, Raja S, Hubner KF. Application of wholebody positron emission tomography in the imaging of esophageal cancer: report of a case. Surg Today 1995; 25: 261-4.
    • (1995) Surg Today , vol.25 , pp. 261-264
    • Yasuda, S.1    Raja, S.2    Hubner, K.F.3
  • 23
    • 0031811481 scopus 로고    scopus 로고
    • Evaluation of esophageal cancers using fluorine-18-fluorodeoxyglucose PET
    • Fukunaga T, Okazumi S, Koide Y, et al. Evaluation of esophageal cancers using fluorine-18-fluorodeoxyglucose PET. J Nucl Med 1998; 39: 1002-7.
    • (1998) J Nucl Med , vol.39 , pp. 1002-1007
    • Fukunaga, T.1    Okazumi, S.2    Koide, Y.3
  • 24
    • 0033871165 scopus 로고    scopus 로고
    • Clinical staging of esophageal carcinoma. CT, EUS, and PET
    • Rice TW. Clinical staging of esophageal carcinoma. CT, EUS, and PET. Chest Surg Clin N Am 2000; 10: 471-85.
    • (2000) Chest Surg Clin N Am , vol.10 , pp. 471-485
    • Rice, T.W.1
  • 25
    • 84857956108 scopus 로고    scopus 로고
    • Applications of PETCT in patients with esophageal cancer
    • Karaosmanoǧlu AD, Blake MA. Applications of PETCT in patients with esophageal cancer. Diagn Interv Radiol. 2012; 18: 171-82.
    • (2012) Diagn Interv Radiol. , vol.18 , pp. 171-182
    • Karaosmanoǧlu, A.D.1    Blake, M.A.2
  • 26
    • 80053136835 scopus 로고    scopus 로고
    • Microvascular architecture of early esophageal neoplasia
    • Kaga M, Inoue H, Kudo SE, et al. Microvascular architecture of early esophageal neoplasia. Oncol Rep 2011; 26: 1063-7.
    • (2011) Oncol Rep , vol.26 , pp. 1063-1067
    • Kaga, M.1    Inoue, H.2    Kudo, S.E.3
  • 27
    • 29144475344 scopus 로고    scopus 로고
    • Evaluation of microvascular patterns of superficial esophageal cancers by magnifying endoscopy
    • Arima M, Tada M, Arima H. Evaluation of microvascular patterns of superficial esophageal cancers by magnifying endoscopy. Esophagus 2005; 2: 191-7.
    • (2005) Esophagus , vol.2 , pp. 191-197
    • Arima, M.1    Tada, M.2    Arima, H.3
  • 28
    • 10844270611 scopus 로고    scopus 로고
    • The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma
    • Kato H, Miyazaki T, Nakajima M, et al. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma. Cancer 2005; 103: 148-56.
    • (2005) Cancer , vol.103 , pp. 148-156
    • Kato, H.1    Miyazaki, T.2    Nakajima, M.3
  • 29
    • 25444533327 scopus 로고    scopus 로고
    • Positron emission tomography in esophageal cancer
    • Kato H, Fukuchi M, Miyazaki T, et al. Positron emission tomography in esophageal cancer. Esophagus 2005; 2: 111-21.
    • (2005) Esophagus , vol.2 , pp. 111-121
    • Kato, H.1    Fukuchi, M.2    Miyazaki, T.3
  • 30
    • 0036725534 scopus 로고    scopus 로고
    • Evaluation of esophageal cancer by positron emission tomography
    • Himeno S, Yasuda S, Shimada H, et al. Evaluation of esophageal cancer by positron emission tomography. Jpn J Clin Oncol 2002; 32: 340-6.
    • (2002) Jpn J Clin Oncol , vol.32 , pp. 340-346
    • Himeno, S.1    Yasuda, S.2    Shimada, H.3
  • 31
    • 0033748729 scopus 로고    scopus 로고
    • Clinicopathologic analysis of lymph node metastasis in surgically resected superficial cancer of the thoracic esophagus
    • Endo M, Yoshino K, Kawano T, et al. Clinicopathologic analysis of lymph node metastasis in surgically resected superficial cancer of the thoracic esophagus. Dis Esophagus 2000; 13: 125-9.
    • (2000) Dis Esophagus , vol.13 , pp. 125-129
    • Endo, M.1    Yoshino, K.2    Kawano, T.3
  • 32
    • 38949176017 scopus 로고    scopus 로고
    • Staging investigations for oesophageal cancer: A metaanalysis
    • van Vliet EP, Heijenbrok-Kal MH, Hunink MG, et al. Staging investigations for oesophageal cancer: a metaanalysis. Br J Cancer 2008; 98: 547-57.
    • (2008) Br J Cancer , vol.98 , pp. 547-557
    • van Vliet, E.P.1    Heijenbrok-Kal, M.H.2    Hunink, M.G.3
  • 33
    • 0034666024 scopus 로고    scopus 로고
    • Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma
    • Flamen P, Lerut A, Van Cutsem E, et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 2000; 18: 3202-10.
    • (2000) J Clin Oncol , vol.18 , pp. 3202-3210
    • Flamen, P.1    Lerut, A.2    van Cutsem, E.3
  • 34
    • 67349151057 scopus 로고    scopus 로고
    • Dual-time-point FDG PET for the evaluation of locoregional lymph nodes in thoracic esophageal squamous cell cancer
    • Hu Q, Wang W, Zhong X, et al. Dual-time-point FDG PET for the evaluation of locoregional lymph nodes in thoracic esophageal squamous cell cancer. Eur J Radiol 2009; 70: 320-4.
    • (2009) Eur J Radiol , vol.70 , pp. 320-324
    • Hu, Q.1    Wang, W.2    Zhong, X.3
  • 35
    • 54949108564 scopus 로고    scopus 로고
    • The additional value of integrated PET/CT over PET in initial lymph node staging of esophageal cancer
    • Kato H, Kimura H, Nakajima M, et al. The additional value of integrated PET/CT over PET in initial lymph node staging of esophageal cancer. Oncol Rep 2008; 20: 857-62.
    • (2008) Oncol Rep , vol.20 , pp. 857-862
    • Kato, H.1    Kimura, H.2    Nakajima, M.3
  • 36
    • 33847022740 scopus 로고    scopus 로고
    • The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: Results of the American College of Surgeons Oncology Group Z0060 trial
    • Meyers BF, Downey RJ, Decker PA, et al. The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trial. J Thorac Cardiovasc Surg 2007; 133: 738-45.
    • (2007) J Thorac Cardiovasc Surg , vol.133 , pp. 738-745
    • Meyers, B.F.1    Downey, R.J.2    Decker, P.A.3
  • 37
    • 30544452120 scopus 로고    scopus 로고
    • A prospective evaluation of the impact of 18-F-fluoro-deoxy-D-glucose positron emission tomography staging on survival for patients with locally advanced esophageal cancer
    • Blackstock AW, Farmer MR, Lovato J, et al. A prospective evaluation of the impact of 18-F-fluoro-deoxy-D-glucose positron emission tomography staging on survival for patients with locally advanced esophageal cancer. Int J Radiat Oncol Biol Phys 2006; 64: 455-60.
    • (2006) Int J Radiat Oncol Biol Phys , vol.64 , pp. 455-460
    • Blackstock, A.W.1    Farmer, M.R.2    Lovato, J.3
  • 38
    • 0032744666 scopus 로고    scopus 로고
    • Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans
    • discussion 1136-7
    • Luketich JD, Friedman DM, Weigel TL, et al. Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans. Ann Thorac Surg 1999; 68: 1133-6; discussion 1136-7.
    • (1999) Ann Thorac Surg , vol.68 , pp. 1133-1136
    • Luketich, J.D.1    Friedman, D.M.2    Weigel, T.L.3
  • 39
    • 28444476152 scopus 로고    scopus 로고
    • Comparison between whole-body positron emission tomography and bone scintigraphy in evaluating bony metastases of esophageal carcinomas
    • Kato H, Miyazaki T, Nakajima M, et al. Comparison between whole-body positron emission tomography and bone scintigraphy in evaluating bony metastases of esophageal carcinomas. Anticancer Res 2005; 25: 4439-44.
    • (2005) Anticancer Res , vol.25 , pp. 4439-4444
    • Kato, H.1    Miyazaki, T.2    Nakajima, M.3
  • 40
    • 0031759361 scopus 로고    scopus 로고
    • Detection of bone metastases in breast cancer by 18FDG PET: Differing metabolic activity in osteoblastic and osteolytic lesions
    • Cook GJ, Houston S, Rubens R, et al. Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol 1998; 16: 3375-9.
    • (1998) J Clin Oncol , vol.16 , pp. 3375-3379
    • Cook, G.J.1    Houston, S.2    Rubens, R.3
  • 41
    • 11144337719 scopus 로고    scopus 로고
    • Positron emission tomography with F-18-fluorodeoxyglucose in a combined staging strategy of esophageal cancer prevents unnecessary surgical explorations
    • van Westreenen HL, Heeren PA, van Dullemen HM, et al. Positron emission tomography with F-18-fluorodeoxyglucose in a combined staging strategy of esophageal cancer prevents unnecessary surgical explorations. J Gastrointest Surg 2005; 9: 54-61.
    • (2005) J Gastrointest Surg , vol.9 , pp. 54-61
    • van Westreenen, H.L.1    Heeren, P.A.2    van Dullemen, H.M.3
  • 42
    • 33745576520 scopus 로고    scopus 로고
    • Significant clinical impact and prognostic stratification provided by FDG-PET in the staging of oesophageal cancer
    • Duong CP, Demitriou H, Weih L, et al. Significant clinical impact and prognostic stratification provided by FDG-PET in the staging of oesophageal cancer. Eur J Nucl Med Mol Imaging 2006; 33: 759-69.
    • (2006) Eur J Nucl Med Mol Imaging , vol.33 , pp. 759-769
    • Duong, C.P.1    Demitriou, H.2    Weih, L.3
  • 43
    • 0033637734 scopus 로고    scopus 로고
    • The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer
    • Flamen P, Lerut A, Van Cutsem E, et al. The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer. J Thorac Cardiovasc Surg 2000; 120: 1085-92.
    • (2000) J Thorac Cardiovasc Surg , vol.120 , pp. 1085-1092
    • Flamen, P.1    Lerut, A.2    van Cutsem, E.3
  • 44
    • 83355165064 scopus 로고    scopus 로고
    • Efficacy and drawbacks of neoadjuvant chemoradiotherapy in squamous cell carcinoma of the thoracic esophagus
    • Wolfárd A, Paszt A, Szentpáli K, et al. Efficacy and drawbacks of neoadjuvant chemoradiotherapy in squamous cell carcinoma of the thoracic esophagus. Hepatogastroenterology 2011; 58: 1214-9.
    • (2011) Hepatogastroenterology , vol.58 , pp. 1214-1219
    • Wolfárd, A.1    Paszt, A.2    Szentpáli, K.3
  • 46
    • 78650509692 scopus 로고    scopus 로고
    • Phase II study of preoperative pemetrexed, carboplatin, and radiation followed by surgery for locally advanced esophageal cancer and gastroesophageal junction tumors
    • Jatoi A, Soori G, Foster NR, et al. Phase II study of preoperative pemetrexed, carboplatin, and radiation followed by surgery for locally advanced esophageal cancer and gastroesophageal junction tumors. J Thorac Oncol 2010; 5: 1994-8.
    • (2010) J Thorac Oncol , vol.5 , pp. 1994-1998
    • Jatoi, A.1    Soori, G.2    Foster, N.R.3
  • 48
    • 77956082599 scopus 로고    scopus 로고
    • Neoadjuvant chemoradiotherapy for esophageal cancer: A review of meta-analyses
    • Wijnhoven BP, van Lanschot JJ, Tilanus HW, et al. Neoadjuvant chemoradiotherapy for esophageal cancer: a review of meta-analyses. World J Surg 2009; 33: 2606-14.
    • (2009) World J Surg , vol.33 , pp. 2606-2614
    • Wijnhoven, B.P.1    van Lanschot, J.J.2    Tilanus, H.W.3
  • 49
    • 77951144091 scopus 로고    scopus 로고
    • Current management of esophageal squamous-cell carcinoma in Japan and other countries
    • Higuchi K, Koizumi W, Tanabe S, et al. Current management of esophageal squamous-cell carcinoma in Japan and other countries. Gastrointest Cancer Res 2009; 3: 153-61.
    • (2009) Gastrointest Cancer Res , vol.3 , pp. 153-161
    • Higuchi, K.1    Koizumi, W.2    Tanabe, S.3
  • 50
    • 20144389053 scopus 로고    scopus 로고
    • The effectiveness of planned esophagectomy after neoadjuvant chemoradiotherapy for advanced esophageal carcinomas
    • Kato H, Fukuchi M, Manda R, et al. The effectiveness of planned esophagectomy after neoadjuvant chemoradiotherapy for advanced esophageal carcinomas. Anticancer Res 2004; 24: 4091-6.
    • (2004) Anticancer Res , vol.24 , pp. 4091-4096
    • Kato, H.1    Fukuchi, M.2    Manda, R.3
  • 51
    • 84862810813 scopus 로고    scopus 로고
    • Nomograms for prognostication of outcome in patients with esophageal and gastroesophageal carcinoma undergoing definitive chemoradiotherapy
    • Suzuki A, Xiao L, Hayashi Y, et al. Nomograms for prognostication of outcome in patients with esophageal and gastroesophageal carcinoma undergoing definitive chemoradiotherapy. Oncology 2012; 82: 108-13.
    • (2012) Oncology , vol.82 , pp. 108-113
    • Suzuki, A.1    Xiao, L.2    Hayashi, Y.3
  • 52
    • 84655163780 scopus 로고    scopus 로고
    • Clinical significance of salvage esophagectomy for remnant or recurrent cancer following definitive chemoradiotherapy
    • Morita M, Kumashiro R, Hisamatsu Y, et al. Clinical significance of salvage esophagectomy for remnant or recurrent cancer following definitive chemoradiotherapy. J Gastroenterol 2011; 46: 1284-91.
    • (2011) J Gastroenterol , vol.46 , pp. 1284-1291
    • Morita, M.1    Kumashiro, R.2    Hisamatsu, Y.3
  • 53
    • 80053578246 scopus 로고    scopus 로고
    • Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906)
    • Kato K, Muro K, Minashi K, et al. Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906). Int J Radiat Oncol Biol Phys 2011; 81: 684-90.
    • (2011) Int J Radiat Oncol Biol Phys , vol.81 , pp. 684-690
    • Kato, K.1    Muro, K.2    Minashi, K.3
  • 54
    • 20244387586 scopus 로고    scopus 로고
    • Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus
    • Stahl M, Stuschke M, Lehmann N, et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005; 23: 2310-7.
    • (2005) J Clin Oncol , vol.23 , pp. 2310-2317
    • Stahl, M.1    Stuschke, M.2    Lehmann, N.3
  • 55
    • 77950942627 scopus 로고    scopus 로고
    • (18)F-fluorodeoxyglucose positron emission tomography immediately after chemoradiotherapy predicts prognosis in patients with locoregional postoperative recurrent esophageal cancer
    • Jingu K, Kaneta T, Nemoto K, et al. (18)F-fluorodeoxyglucose positron emission tomography immediately after chemoradiotherapy predicts prognosis in patients with locoregional postoperative recurrent esophageal cancer. Int J Clin Oncol 2010; 15: 184-90.
    • (2010) Int J Clin Oncol , vol.15 , pp. 184-190
    • Jingu, K.1    Kaneta, T.2    Nemoto, K.3
  • 56
    • 33644877067 scopus 로고    scopus 로고
    • Comparison of changes in tumor metabolic activity and tumor size during chemotherapy of adenocarcinomas of the esophagogastric junction
    • Wieder HA, Beer AJ, Lordick F, et al. Comparison of changes in tumor metabolic activity and tumor size during chemotherapy of adenocarcinomas of the esophagogastric junction. J Nucl Med 2005; 46: 2029-34.
    • (2005) J Nucl Med , vol.46 , pp. 2029-2034
    • Wieder, H.A.1    Beer, A.J.2    Lordick, F.3
  • 57
    • 0036018910 scopus 로고    scopus 로고
    • Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer
    • Flamen P, Van Cutsem E, Lerut A, et al. Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer. Ann Oncol 2002; 13: 361-8.
    • (2002) Ann Oncol , vol.13 , pp. 361-368
    • Flamen, P.1    van Cutsem, E.2    Lerut, A.3
  • 58
    • 1542438617 scopus 로고    scopus 로고
    • Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: Results of a prospective trial
    • Ott K, Fink U, Becker K, et al. Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial. J Clin Oncol 2003; 21: 4604-10.
    • (2003) J Clin Oncol , vol.21 , pp. 4604-4610
    • Ott, K.1    Fink, U.2    Becker, K.3
  • 59
    • 80455164742 scopus 로고    scopus 로고
    • 18F-FDG PET image-derived parameters for therapy response prediction in oesophageal cancer
    • 18F-FDG PET image-derived parameters for therapy response prediction in oesophageal cancer. Eur J Nucl Med Mol Imaging 2011; 38: 1595-606.
    • (2011) Eur J Nucl Med Mol Imaging , vol.38 , pp. 1595-1606
    • Hatt, M.1    Visvikis, D.2    Pradier, O.3
  • 60
    • 80054800344 scopus 로고    scopus 로고
    • Prognostic significance of baseline positron emission tomography and importance of clinical complete response in patients with esophageal or gastroesophageal junction cancer treated with definitive chemoradiotherapy
    • Suzuki A, Xiao L, Hayashi Y, et al. Prognostic significance of baseline positron emission tomography and importance of clinical complete response in patients with esophageal or gastroesophageal junction cancer treated with definitive chemoradiotherapy. Cancer 2011; 117: 4823-33.
    • (2011) Cancer , vol.117 , pp. 4823-4833
    • Suzuki, A.1    Xiao, L.2    Hayashi, Y.3
  • 61
    • 0028305674 scopus 로고
    • Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations
    • Mandard AM, Dalibard F, Mandard JC, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 1994; 73: 2680-6.
    • (1994) Cancer , vol.73 , pp. 2680-2686
    • Mandard, A.M.1    Dalibard, F.2    Mandard, J.C.3
  • 62
    • 0032815106 scopus 로고    scopus 로고
    • Preoperative chemotherapy for advanced esophageal cancer and relation with histological effect
    • Hosoya Y, Shibusawa H, Nagai H, et al. Preoperative chemotherapy for advanced esophageal cancer and relation with histological effect. Surg Today 1999; 29: 689-94.
    • (1999) Surg Today , vol.29 , pp. 689-694
    • Hosoya, Y.1    Shibusawa, H.2    Nagai, H.3
  • 63
    • 7744234343 scopus 로고    scopus 로고
    • Responders benefit from neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma: Results of a prospective phase-II trial
    • Brücher BL, Stein HJ, Zimmermann F, et al. Responders benefit from neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma: results of a prospective phase-II trial. Eur J Surg Oncol 2004; 30: 963-71.
    • (2004) Eur J Surg Oncol , vol.30 , pp. 963-971
    • Brücher, B.L.1    Stein, H.J.2    Zimmermann, F.3
  • 64
    • 22344446070 scopus 로고    scopus 로고
    • Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival
    • Berger AC, Farma J, Scott WJ, et al. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol 2005; 23: 4330-7.
    • (2005) J Clin Oncol , vol.23 , pp. 4330-4337
    • Berger, A.C.1    Farma, J.2    Scott, W.J.3
  • 65
    • 80051638162 scopus 로고    scopus 로고
    • Neoadjuvant chemoradiotherapy for clinical stage II-III esophageal squamous cell carcinoma
    • Saeki H, Morita M, Nakashima Y, et al. Neoadjuvant chemoradiotherapy for clinical stage II-III esophageal squamous cell carcinoma. Anticancer Res 2011; 31: 3073-7.
    • (2011) Anticancer Res , vol.31 , pp. 3073-3077
    • Saeki, H.1    Morita, M.2    Nakashima, Y.3
  • 66
    • 79959345610 scopus 로고    scopus 로고
    • Quantifying the benefit of a pathologic complete response after neoadjuvant chemoradiotherapy in the treatment of esophageal cancer
    • Scheer RV, Fakiris AJ, Johnstone PA. Quantifying the benefit of a pathologic complete response after neoadjuvant chemoradiotherapy in the treatment of esophageal cancer. Int J Radiat Oncol Biol Phys 2011; 80: 996-1001.
    • (2011) Int J Radiat Oncol Biol Phys , vol.80 , pp. 996-1001
    • Scheer, R.V.1    Fakiris, A.J.2    Johnstone, P.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.